Akira Sakuma

792 total citations
58 papers, 581 citations indexed

About

Akira Sakuma is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Akira Sakuma has authored 58 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Molecular Biology. Recurrent topics in Akira Sakuma's work include Cardiovascular Syncope and Autonomic Disorders (4 papers), Peripheral Artery Disease Management (4 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Akira Sakuma is often cited by papers focused on Cardiovascular Syncope and Autonomic Disorders (4 papers), Peripheral Artery Disease Management (4 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Akira Sakuma collaborates with scholars based in Japan, United States and Italy. Akira Sakuma's co-authors include Tomio Narisawa, Sachiko Oh‐ishi, Hiroshi Nakano, Hisanobu Niitani, Kōichi Nagao, Hiroshi Kurisaki, Seiitsu Ono, Kiyoyuki Furuse, Mitsumasa Ogawara and Shukichi Sakaguchi and has published in prestigious journals such as Cancer, The American Journal of Cardiology and Biochemical Pharmacology.

In The Last Decade

Akira Sakuma

53 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akira Sakuma Japan 14 114 106 98 97 74 58 581
Karen S. Blisard United States 15 166 1.5× 26 0.2× 44 0.4× 71 0.7× 82 1.1× 41 566
Michael K. Elson United States 16 151 1.3× 64 0.6× 60 0.6× 37 0.4× 84 1.1× 32 631
A C Papp United States 15 464 4.1× 70 0.7× 117 1.2× 84 0.9× 57 0.8× 29 986
Susumu Matsuda Japan 12 156 1.4× 96 0.9× 69 0.7× 84 0.9× 122 1.6× 24 694
Etienne J. Nouwen Belgium 14 211 1.9× 88 0.8× 47 0.5× 50 0.5× 84 1.1× 21 712
Joost Daalhuisen Netherlands 15 337 3.0× 73 0.7× 79 0.8× 111 1.1× 164 2.2× 19 935
L Dénès Hungary 9 163 1.4× 49 0.5× 59 0.6× 27 0.3× 32 0.4× 22 537
H Yano Japan 12 217 1.9× 72 0.7× 76 0.8× 43 0.4× 144 1.9× 36 523
Tiziana Adage Austria 13 202 1.8× 146 1.4× 70 0.7× 42 0.4× 46 0.6× 27 666
Roland Sauer Germany 12 175 1.5× 30 0.3× 81 0.8× 113 1.2× 29 0.4× 17 510

Countries citing papers authored by Akira Sakuma

Since Specialization
Citations

This map shows the geographic impact of Akira Sakuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akira Sakuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akira Sakuma more than expected).

Fields of papers citing papers by Akira Sakuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akira Sakuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akira Sakuma. The network helps show where Akira Sakuma may publish in the future.

Co-authorship network of co-authors of Akira Sakuma

This figure shows the co-authorship network connecting the top 25 collaborators of Akira Sakuma. A scholar is included among the top collaborators of Akira Sakuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akira Sakuma. Akira Sakuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Mingxia, Tomonori Ohba, Katsumi Kaneko, et al.. (2013). Electron Density Modification of Single Wall Carbon Nanotubes (SWCNT) by Liquid-Phase Molecular Adsorption of Hexaiodobenzene. Materials. 6(2). 535–543. 11 indexed citations
3.
Furuse, Kiyoyuki, Mitsumasa Ogawara, Masakichi Motomiya, et al.. (1994). A Phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Lung Cancer. 11(5-6). 385–391. 67 indexed citations
4.
Gotō, Yoshio, Nigishi Hotta, Y. Shigeta, et al.. (1993). A Placebo‐controlled Double‐blind Study of Epalrestat (ONO‐2235) in Patients with Diabetic Neuropathy. Diabetic Medicine. 10(S2). 39S–43S. 23 indexed citations
5.
Niitani, Hirokazu, Tsuneaki Sugimoto, Kazumasa Hiejima, et al.. (1992). Clinical Evaluation of Pilsicainide Hydrochloride (SUN 1165) in Patients with Supraventricular Premature Contractions. A Multicenter Double-Blind Dose Finding Study.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 23(3). 557–572. 1 indexed citations
6.
Nakajima, Tohru, Yasuo Tajima, Isamu Sugano, et al.. (1992). A case of carcinoma in pleomorphic adenoma of lacrimal gland: a study of imprint cytology.. The Journal of the Japanese Society of Clinical Cytology. 31(3). 489–492. 1 indexed citations
7.
Sakuma, Akira. (1990). Inference on the fuzzy equivalence.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 21(4). 765–769. 1 indexed citations
8.
Matsubara, Yoshihiro, et al.. (1990). Clinical efficacy and safety of dobutamine hydrochloride: Patients' profiles.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 21(4). 703–712. 1 indexed citations
10.
Niitani, Hirokazu, Tsuneaki Sugimoto, Kiyoshi Kawakubo, et al.. (1989). Clinical evaluation of SUN 1165 in patients with ventricular premature contractions - A multicenter double-blind dose finding study.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 20(4). 719–733. 2 indexed citations
11.
Sakuma, Akira, et al.. (1989). Medical data file of a university hospital as a possible source of postmarketing surveillance. Report No. 1.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 20(3). 597–605.
12.
Fukuyama, Yukio, Kenji Nihei, Shuzo Matsumoto, et al.. (1987). Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitis. Brain and Development. 9(3). 270–282. 30 indexed citations
13.
Sakaguchi, Shukichi, et al.. (1985). Clinical evaluation of defibrinogenation therapy(batroxobin) on chronic arterial occlusive disease. Double-blind study in comparison with niceritol.. 1(10). 1413–1427. 1 indexed citations
14.
Matsumoto, Keizō, Akira Sakuma, Masato Hayashi, et al.. (1984). Clinical Evaluation of Oxaprozin in the Treatment of Acute Upper Respiratory Tract Inflammations. Kansenshogaku zasshi. 58(7). 628–646. 2 indexed citations
15.
Sakuma, Akira, et al.. (1984). . Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 15(3). 455–462.
16.
Sobue, I, Tetsuya Takayanagi, Takao Nakanishi, et al.. (1983). Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations. Journal of the Neurological Sciences. 61(2). 235–248. 66 indexed citations
17.
Sakuma, Akira, et al.. (1982). The relationship between the Mantel-Haenszel statistic and the Wilcoxon two-sample statistic.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 13(3). 449–455.
18.
Sakuma, Akira, et al.. (1976). Standardization of an Objective Test of Motor Recovery in Hemiplegia (I). Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 7(3). 271–280. 1 indexed citations
19.
Oh‐ishi, Sachiko & Akira Sakuma. (1970). A MODEL FOR RAT PAW EDEMA. The Japanese Journal of Pharmacology. 20(3). 349–359. 4 indexed citations
20.
Sakai, Fuminori, Akira Sakuma, Yasuo Otsuka, Yoshiaki Saji, & Hiroshi Kumagai. (1962). Wirkung der Hypo- und Hyperventilation auf das Elektrencephalogramm. Naunyn-Schmiedeberg s Archives of Pharmacology. 244(2). 145–152. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026